News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
853,797 Results
Type
Article (86956)
Company Profile (704)
Press Release (766136)
Multimedia
Podcasts (150)
Webinars (19)
Section
Business (232855)
Career Advice (4133)
Deals (39768)
Drug Delivery (130)
Drug Development (91129)
Employer Resources (199)
FDA (18205)
Job Trends (17369)
News (396925)
Policy (39833)
Tag
Academia (3002)
Academic (2)
Accelerated approval (13)
Adcomms (33)
Allergies (109)
Alliances (56975)
ALS (122)
Alzheimer's disease (1599)
Antibody-drug conjugate (ADC) (192)
Approvals (18156)
Artificial intelligence (405)
Autoimmune disease (39)
Automation (19)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (103)
Brain cancer (41)
Breast cancer (402)
Cancer (3180)
Cardiovascular disease (253)
Career advice (3542)
Career pathing (34)
CAR-T (213)
CDC (42)
Cell therapy (586)
Cervical cancer (25)
Clinical research (74442)
Collaboration (1143)
Company closure (3)
Compensation (732)
Complete response letters (37)
COVID-19 (2911)
CRISPR (69)
C-suite (382)
Cystic fibrosis (124)
Data (3203)
Decentralized trials (2)
Denatured (53)
Depression (81)
Diabetes (383)
Diagnostics (6991)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (190)
Drug pricing (155)
Drug shortages (36)
Duchenne muscular dystrophy (157)
Earnings (97683)
Editorial (50)
Employer branding (25)
Employer resources (169)
Events (131583)
Executive appointments (920)
FDA (20029)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1034)
Gene editing (151)
Generative AI (41)
Gene therapy (459)
GLP-1 (942)
Government (5278)
Grass and pollen (7)
Guidances (193)
Healthcare (20919)
HIV (46)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (190)
Immuno-oncology (13)
Indications (42)
Infectious disease (3115)
Inflammatory bowel disease (166)
Inflation Reduction Act (13)
Influenza (76)
Intellectual property (128)
Interviews (813)
IPO (17907)
IRA (56)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (59)
Layoffs (599)
Leadership (27)
Legal (10138)
Liver cancer (85)
Longevity (12)
Lung cancer (444)
Lymphoma (221)
Machine learning (12)
Management (65)
Manufacturing (471)
MASH (101)
Medical device (14745)
Medtech (14751)
Mergers & acquisitions (22602)
Metabolic disorders (974)
Multiple sclerosis (106)
NASH (23)
Neurodegenerative disease (159)
Neuropsychiatric disorders (46)
Neuroscience (2383)
NextGen: Class of 2025 (7687)
Non-profit (5091)
Now hiring (50)
Obesity (497)
Opinion (291)
Ovarian cancer (105)
Pain (126)
Pancreatic cancer (132)
Parkinson's disease (203)
Partnered (25)
Patents (329)
Patient recruitment (182)
Peanut (55)
People (65782)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22968)
Phase II (32323)
Phase III (24344)
Pipeline (1760)
Policy (248)
Postmarket research (3553)
Preclinical (10373)
Press Release (72)
Prostate cancer (156)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (538)
Real estate (7402)
Recruiting (76)
Regulatory (27289)
Reports (62)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (12)
RSV (61)
Schizophrenia (102)
Series A (174)
Series B (119)
Service/supplier (30)
Sickle cell disease (68)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (37)
Startups (4307)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (70)
The Weekly (95)
Vaccines (934)
Venture capital (59)
Weight loss (334)
Women's health (52)
Worklife (20)
Date
Today (123)
Last 7 days (534)
Last 30 days (1857)
Last 365 days (33934)
2025 (19336)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1275)
Alabama (72)
Alaska (7)
Arizona (281)
Arkansas (14)
Asia (50584)
Australia (8887)
California (7953)
Canada (2456)
China (739)
Colorado (341)
Connecticut (353)
Delaware (212)
Europe (116085)
Florida (1180)
Georgia (272)
Hawaii (3)
Idaho (67)
Illinois (754)
India (34)
Indiana (393)
Iowa (19)
Japan (244)
Kansas (116)
Kentucky (33)
Louisiana (18)
Maine (73)
Maryland (1125)
Massachusetts (6087)
Michigan (279)
Minnesota (497)
Mississippi (4)
Missouri (107)
Montana (32)
Nebraska (26)
Nevada (86)
New Hampshire (74)
New Jersey (2234)
New Mexico (31)
New York (2223)
North Carolina (1259)
North Dakota (10)
Northern California (3445)
Ohio (257)
Oklahoma (17)
Oregon (48)
Pennsylvania (1700)
Puerto Rico (18)
Rhode Island (40)
South America (1654)
South Carolina (36)
South Dakota (1)
Southern California (2954)
Tennessee (130)
Texas (1222)
United States (30001)
Utah (231)
Virginia (219)
Washington D.C. (80)
Washington State (699)
West Virginia (4)
Wisconsin (87)
There are 853,797 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
AstraZeneca CEO Says World ‘Needs to Share’ in Global Pharma R&D
Pascal Soriot’s comments came during AstraZeneca’s Q2 earnings call in regard to President Donald Trump’s newly announced European pharma tariffs. The company also announced estimate-beating earnings, with its cancer portfolio driving earnings despite clinical roadblocks.
July 29, 2025
·
3 min read
·
Tristan Manalac
Earnings
Merck Cuts $3B to Support Aggressive Launch Schedule, Late-Stage R&D
CEO Rob Davis referred to the cost reduction program as a ‘reallocation’ rather than a cut, with the savings to be reinvested to support up to 20 new product launches.
July 29, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Nausea Medicine Market Poised to Hit USD 4.86 Billion by 2032 as Cancer Treatments Intensify | Coherent Market Insights
July 29, 2025
·
1 min read
C-suite
Novo Nordisk Names New Leader, Cuts 2025 Sales Guidance By 5%
In a surprise double announcement Tuesday, Novo reduced sales guidance by 5%—attributing the change to slowed growth of its semaglutide franchise in the U.S.—and named current international operations head Maziar Mike Doustdar as its new president and CEO.
July 29, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Lyophilized Injectable Drug Market Size to Surpass USD 1,330.78 Bn by 2034 Amidst Surging Demand for Biologics and Oncology Therapies
July 29, 2025
·
1 min read
Regulatory
Senate Democrats Investigating HHS Secretary Kennedy’s ACIP Firing
Six weeks after HHS Secretary RFK Jr. cited unexplained conflicts of interest in dismissing all 17 members of the CDC’s vaccine advisory committee, Democrats are asking for details.
July 29, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Genomics Market Surges with PCR and AI Technologies Projected to Reach USD 175.18 Billion by 2034
July 29, 2025
·
1 min read
Layoff Tracker
Adaptimmune Expects To Cut 62% of Staff After Cell Therapy Asset Sale
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
July 29, 2025
·
170 min read
·
BioSpace Editorial Staff
Press Releases
GeneToBe, Inc. Appoints New CEO Amid Strategic Leadership Changes and Adds Key Consultants to Advance Gene Therapy Pipeline
July 29, 2025
·
1 min read
Press Releases
Diorasis Therapeutics and Northway Biotech Announce Partnership for the Development and Manufacturing of AAV Gene Therapy for Glaucoma
July 29, 2025
·
1 min read
1 of 85,380
Next
